Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813501 · ClinicalTrials.gov registry record
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
A clinical trial, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- 60
- Enrollment target
NCT00813501 is a clinical trial that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT00813501 was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment. PURPOSE: This clinical trial is studying an immunologic diagnostic blood test to see how well it works in predicting side-effects in patients with hematologic cancer or other disorders who have undergone a donor stem cell transplant.
Interventions
- PROCEDURE allogeneic hematopoietic stem cell transplantation
- OTHER immunological diagnostic method
- BIOLOGICAL immunosuppressive therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813501
The ClinicalTrials.gov registry entry for NCT00813501 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which allogeneic hematopoietic stem cell transplantation is the first listed.
NCT00813501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813501 about?
NCT00813501 is a clinical study titled "Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases". RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment. PURPOSE: This clinical trial is studying an immunologic diagnostic blood test to see how well it works in predicting side-effect...
What is the current status of trial NCT00813501?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2008-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00813501?
The interventions under investigation include: allogeneic hematopoietic stem cell transplantation (PROCEDURE), immunological diagnostic method (OTHER), immunosuppressive therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00813501?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.